1,819
Views
5
CrossRef citations to date
0
Altmetric
Cardiology & Cardiovascular Disorders

Helicobacter pylori increases the risk of carotid plaque formation: a clinical evidence

, , , &
Pages 1448-1454 | Received 01 Mar 2021, Accepted 04 May 2021, Published online: 25 Aug 2021

References

  • Franceschi F, Gasbarrini A. Helicobacter pylori and extragastric diseases. Best Pract Res Clin Gastroenterol. 2007;21(2):325–334.
  • Fan XG, Yakoob J, Chua A, et al. Helicobacter pylori‐induced lipid peroxidation in peripheral blood lymphocytes. APMIS. 1995;103(1–6):316–320.
  • Keikha M, Karbalaei M. EPIYA motifs of Helicobacter pylori cagA genotypes and gastrointestinal diseases in the Iranian population: a systematic review and meta-analysis. New Microbes New Infect. 2021;41:100865.
  • Pichon M, Burucoa C. Impact of the gastro-intestinal bacterial microbiome on Helicobacter-associated diseases. Healthcare. 2019;7(1):34.
  • White JR, Winter JA, Robinson K. Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes. J Inflamm Res. 2015;8:137.
  • Wang H, Ni X, Qing X, et al. Live probiotic Lactobacillus johnsonii BS15 promotes growth performance and lowers fat deposition by improving lipid metabolism, intestinal development, and gut microflora in broilers. Front Microbiol. 2017;8:1073.
  • Pietroiusti A, Diomedi M, Silvestrini M, et al. Cytotoxin-associated gene-A–positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation. 2002;106(5):580–584.
  • Sheh A, Fox JG. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes. 2013;4(6):505–531.
  • Zhu J, Katz RJ, Quyyumi AA, et al. Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis. Circulation. 2004;109(1):36–41.
  • Kucukazman M, Yavuz B, Sacikara M, et al. The relationship between updated Sydney System score and LDL cholesterol levels in patients infected with Helicobacter pylori. Dig Dis Sci. 2009;54(3):604–607.
  • Masoud SA, Arami MA, Kucheki E. Association between infection with Helicobacter pylori and cerebral noncardioembolic ischemic stroke. Neurol India. 2005;53(3):303–306. Sepdiscussion 6–7.
  • Kim H-L, Jeon HH, Park IY, et al. Helicobacter pylori infection is associated with elevated low density lipoprotein cholesterol levels in elderly Koreans. J Korean Med Sci. 2011;26(5):654.
  • Satoh H, Saijo Y, Yoshioka E, et al. Helicobacter Pylori infection is a significant risk for modified lipid profile in Japanese male subjects. JAT. 2010;17(10):1041–1048.
  • Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J. 2010;103(3):190–196.
  • Gu L, Li S, He Y, et al. Bismuth, rabeprazole, amoxicillin, and doxycycline as first‐line Helicobacter pylori therapy in clinical practice: a pilot study. Helicobacter. 2019;24(4):e12594.
  • Dai H, Wang W, Chen R, et al. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab (Lond). 2017;14(1):1–9.
  • Makita S, Nakamura M, Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke. 2005;36(10):2138–2142.
  • Akbas HS, Basyigit S, Suleymanlar I, et al. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects. Lipids Health Dis. 2010;9(1):92. 2010/08/30
  • Laurila A, Bloigu A, Näyhä S, et al. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis. 1999;142(1):207–210.
  • Akbas HS, Basyigit S, Suleymanlar I, et al. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects. Lipids Health Dis. 2010;9(1):1–6.
  • Grunfeld C, Gulli R, Moser A, et al. Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res. 1989;30(4):579–585.
  • Dogan Z, Sarikaya M, Ergul B, et al. The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(2):242–245.
  • Rahman A, Cope MB, Sarker SA, et al. Helicobacter pylori infection and inflammation: implications for pathophysiology of diabetes mellitus and coronary heart disease. J Life Sci. 2009;1(1):45–50.
  • Anastasios R, Goritsas C, Papamihail C, et al. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med. 2002;13(6):376–379.
  • Schöttker B, Adamu MA, Weck MN, et al. Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis. 2012;220(2):569–574.
  • Yu XJ, Yang X, Feng L, et al. Association between Helicobacter pylori infection and angiographically demonstrated coronary artery disease: a meta-analysis. Exp Ther Med. 2017;13(2):787–793.
  • Tabata N, Sueta D, Akasaka T, et al. Helicobacter pylori seropositivity in patients with interleukin-1 polymorphisms is significantly associated with ST-segment elevation myocardial infarction. PLoS One. 2016;11(11):e0166240.
  • Gabrielli M, Santoliquido A, Cremonini F, et al. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke. Eur Heart J. 2004;25(1):64–68.
  • Markus HS, Risley P, Mendall MA, et al. Helicobacter pylori infection, the cytotoxin gene A strain, and carotid artery intima-media thickness. J Cardiovasc Risk. 2002;9(1):1–6.
  • Rožanković PB, Huzjan AL, Čupić H, et al. Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease. J Neurol. 2011;258(5):753–761.
  • Sawayama Y, Ariyama I, Hamada M, et al. Association between chronic Helicobacter pylori infection and acute ischemic stroke: Fukuoka Harasanshin Atherosclerosis Trial (FHAT). Atherosclerosis. 2005;178(2):303–309.
  • Shan J, Bai X, Han L, et al. Association between atherosclerosis and gastric biomarkers concerning Helicobacter pylori infection in a Chinese healthy population. Exp Gerontol. 2018;112:97–102.
  • Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ. 1998;316(7138):1130–1132.
  • Nagai Y, Matsumoto M, Metter EJ. The carotid artery as a noninvasive window for cardiovascular risk in apparently healthy individuals. Ultrasound Med Biol. 2002;28(10):1231–1238.
  • Zhang L, Chen Z, Xia X, et al. Helicobacter pylori infection selectively increases the risk for carotid atherosclerosis in young males. Atherosclerosis. 2019;291:71–77.
  • Vizzardi E, Bonadei I, Piovanelli B, et al. Helicobacter pylori and ischemic heart disease. Panminerva Med. 2011;53(3):193–202.